N-[5-({3-[5-(Acetyl-hydroxy-amino)-pentylcarbamoyl]-propionyl}-hydroxy-amino)-pentyl]-N'-hydroxy-N'-(5-{[3-(4-nitro-phenyl)-adamantane-1-carbonyl]-amino}-pentyl)-succinamide

ID: ALA4206976

Chembl Id: CHEMBL4206976

PubChem CID: 145976180

Max Phase: Preclinical

Molecular Formula: C42H65N7O11

Molecular Weight: 844.02

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)C12CC3CC(C1)CC(c1ccc([N+](=O)[O-])cc1)(C3)C2

Standard InChI:  InChI=1S/C42H65N7O11/c1-31(50)46(56)22-8-2-5-19-43-36(51)15-17-38(53)47(57)23-9-3-6-20-44-37(52)16-18-39(54)48(58)24-10-4-7-21-45-40(55)42-28-32-25-33(29-42)27-41(26-32,30-42)34-11-13-35(14-12-34)49(59)60/h11-14,32-33,56-58H,2-10,15-30H2,1H3,(H,43,51)(H,44,52)(H,45,55)

Standard InChI Key:  VSEHCUZBFGLGOS-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4206976

    ---

Associated Targets(Human)

SK-N-BE(2)-M17 (195 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Astrocyte (46 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 844.02Molecular Weight (Monoisotopic): 843.4742AlogP: 4.53#Rotatable Bonds: 27
Polar Surface Area: 252.06Molecular Species: NEUTRALHBA: 11HBD: 6
#RO5 Violations: 3HBA (Lipinski): 18HBD (Lipinski): 6#RO5 Violations (Lipinski): 3
CX Acidic pKa: 7.92CX Basic pKa: 0.48CX LogP: 1.78CX LogD: 1.65
Aromatic Rings: 1Heavy Atoms: 60QED Weighted: 0.03Np Likeness Score: -0.32

References

1. Telfer TJ, Liddell JR, Duncan C, White AR, Codd R..  (2017)  Adamantyl- and other polycyclic cage-based conjugates of desferrioxamine B (DFOB) for treating iron-mediated toxicity in cell models of Parkinson's disease.,  27  (8): [PMID:28285915] [10.1016/j.bmcl.2017.03.001]

Source